跳至主要内容
临床试验/NCT03742531
NCT03742531已完成2 期

Does Induction Dosage in Latent Phase Affect Active Phase of Labor?A Randomized Study

Zeynep Kamil Maternity and Pediatric Research and Training Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年12月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
need for oxytocin retreatment

研究概览

简要总结

This study evaluates the need of oxytocin therapy in active phase of labor. there will be two groups treating with oxytocin in latent phase.One group will be treated with low dose oxytocin therapy and the other group will be treated with high dose oxytocin therapy. oxytocin treatment will be ceased at the beginning of the active phase of labor. the need of oxytocin treatment in active phase of labor will be compared between two groups.

详细描述

Oxytocin treatment in active phase of labour is used with respect to clinicians preference and best approach has not been described. We want to investigate the effect of oxytocin treatment by using different regims in latent phase of labor when oxytocin treatment is ceased in active phase of labour. In our trial we discontinued oxytocin in active phase of labour and investigate which group needs oxytocin therapy due to inadequate uterine contractions and arrest of labor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Live fetus in cephalic presentation, sonographically estimated fetal weight less than 4200 g, undergoing induction of labor at 37-42 weeks of gestation, having indications of labor, no previous uterine surgery

排除标准

  • malpresentation, placenta previa, previous uterine surgery, multiple gestation, active genital herpes, non-reassuring fetal heart rate pattern

研究组 & 干预措施

low dose group

Active Comparator

oxytocin therapy starting with 2mU/min increased by 2 mU/min every 15 minutes. oxytocin will be stopped at the beginning of the active phase of labor.

干预措施: oxytocin (Drug)

high dose group

Active Comparator

oxytocin therapy starting with 4mU/min increased by 4 mU/min every 15 minutes. oxytocin will be stopped at the beginning of the active phase of labor.

干预措施: oxytocin (Drug)

结局指标

主要结局

need for oxytocin retreatment

时间窗: an average of one year

need for oxytocin retreatment due to inadequate uterine contractions and labor arrest

次要结局

  • total oxytocin dose(an average of one year)
  • APGAR scores(an average of one year)
  • length of active phase(an average of one year)
  • ratio of caesarean section(an average of one year)

研究者

发起方
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmet Eser

principal investigator

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

研究点 (1)

Loading locations...

相似试验

Does Induction Dosage in Latent Phase Affect Active... | 临床试验